Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,413,089
Closed -$11.4M 454
2024
Q3
$11.4M Buy
1,413,089
+145,799
+12% +$5.96M 0.3% 65
2024
Q2
$12.5M Buy
1,267,290
+436,322
+53% +$18.4M 0.17% 84
2024
Q1
$17.9M Buy
+830,968
New +$34.3M 0.33% 64

Other funds holding GSK

Groupama Asset Management's GSK Position: Q4 2024 in Review

Groupama Asset Management sold out of GSK (GSK) in Q4 2024, closing a stake of 1,413,089 shares — an estimated $11.4M sold.

Groupama Asset Management first reported a position in GSK in Q1 2024 and held it in 3 quarters. The position peaked at $17.9M in Q1 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Groupama Asset Management reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Groupama Asset Management sold 1,413,089 GSK shares in Q4 2024, an estimated $11.4M.
  • Groupama Asset Management first reported a position in GSK in Q1 2024 and held it in 3 quarters.
  • Groupama Asset Management's GSK position peaked at $17.9M in Q1 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Groupama Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.